Sublingual Dexmedetomidine for Agitation in Bipolar Disorder, SARS-CoV-2 Infection and Maternal Morbidity and Mortality, Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest, and more
- Author
- American Medical Association
- Published
- Tue 22 Feb 2022
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2021.23223
Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 22, 2022 issue.
